Stock ticker :
NASDAQ
GOCO
AS OF
Jan 14, closing price
Price
$2.94
Change
+$0.02 (+0.68%)
Capitalization
$337.4m
GOCO
Stock ticker :
NASDAQ
48 days until earnings call
Intraday data for
Jan 14, closing price
Price
$2.94
Change
+$0.02 (+0.68%)
Capitalization
$337.4m

(GOCO) Stock Forecast and AI Recommendations

a company which engages in the provision of insurance services and will operates as a holding company
Industry InsuranceBrokersServices

GoHealth (GOCO) Stock Stock Prediciton and Price Targets

Stock market charts, price targets, analyst ratings and a financial calendar
a company which engages in the provision of insurance services and will operates as a holding company
Industry InsuranceBrokersServices
A.I.dvisor published
a Summary for GOCO with price predictions.
4:00 PM EST Jan 14

GOCO in -7.60% downward trend, falling for three consecutive days on January 13, 2022

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where GOCO declined for three days, in 94 of 104 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.

Stock Forecast, Price, News, Quote

Current price $2.94 is below $4.41 the lowest resistance line found by A.I. Throughout the month of 12/14/21 - 01/14/22, the price experienced a -19% Downtrend. During the week of 01/07/22 - 01/14/22, the stock fell -1%.

Technical Analysis (Indicators)
Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 05, 2022. You may want to consider selling the stock, shorting the stock, or exploring put options on GOCO as a result. In 22 of 27 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.

The Moving Average Convergence Divergence Histogram (MACD) for GOCO turned negative on January 06, 2022. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 8 similar instances when the indicator turned negative. In 7 of the 8 cases the stock turned lower in the days that followed. This puts the odds of success at 88%.

The Aroon Indicator for GOCO entered a downward trend on December 27, 2021. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Indicator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a +6.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where GOCO advanced for three days, in 43 of 60 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.

GOCO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GOCO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 64, placing this stock worse than average.

The Tickeron Price Growth Rating for this company is 95 (best 1 - 100 worst), indicating slightly worse than average price growth. GOCO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 76 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.678) is normal, around the industry mean (12.426). P/E Ratio (29.412) is within average values for comparable stocks, (30.295). GOCO's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.650). Dividend Yield (0.000) settles around the average of (0.033) among similar stocks. GOCO's P/S Ratio (0.273) is slightly lower than the industry average of (3.744).

The Tickeron PE Growth Rating for this company is 75 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 7 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.dvisor published
GoHealth Earnings Data

GOCO is expected to report earnings to fall 528.22% to 77 cents per share on March 07

GoHealth GOCO Stock Earnings Report
Q4'21
Est.
$0.77
Q3'21
Missed
by $0.10
Q2'21
Missed
by $0.08
Q1'21
Missed
by $0.02
Q4'20
Met
by $0.42
The last earnings report on November 09 showed earnings per share of -18 cents, missing the estimate of -8 cents. With 1.66M shares outstanding, the current market capitalization sits at 337.44M.
A.I.dvisor
published General Information

General Information

Profile
Fundamentals
Details
Address 214 West Huron Street, Chicago, IL, 60654
Phone +1 312 386-8200
Employees 54
Web https://www.gohealth.com
GOCO

Select Stock attributes to show

Capitalization 337M
P/E Ratio 29.41
Risk (Beta) N/A
Dividend Yield N/A
Total Cash 113M
Total Cash/Share 0.98
Total Debt 419M
Total Debt/Equity N/A
Projected Growth (PEG Ratio) N/A
Revenue/Share (as % of the share price) 11%
Revenue 1.01B
ROE N/A
Book Value 471M
P/B Ratio 0.68
Cash Flow N/A
Earnings -0.284
Average Daily Volume YTD N/A
Common Shares Outstanding - Security Level 32K
Current Ratio 2.60
Current Revenue Per Employee N/A
Dividends Per Share - Security N/A
EBITDA 15.3M
Float N/A
Float - Current N/A
Gross Income Margin N/A
Revenue To Assets -1.80
Shares Held By Institutions 1.052B
Shares Outstanding - Current N/A
Total Liabilities 746M
Total Volume MTD N/A
Value Under
Gain YTD -22.427
Group Domestic Stock Funds
Category Insurance
Total Expense Ratio
Min. Initial Investment 0.00 USD
Fund Existence
Turnover
Front Load
Net Assets 0.00 USD
Manager Tenure
Group Domestic Stock Funds
Category Insurance
Capitalization 337.44m USD
P/E Ratio 29.411764
Total Cash 112.86m USD
Projected Growth N/A
Total Debt 419.18m USD
Revenue 1.01b USD
Risk (Beta) N/A
Dividend Yield N/A
Total Cash/Share 0.98
Total Debt/Equity N/A
Revenue/Share 11.00USD as % of share price
Group Domestic Stock Funds
Category Insurance
Net Assets 0.00 USD
Fund Existence
Turnover
Capitalization
Yield
Total Expense Ratio
Investment Style
Risk (Beta)
Group Domestic Stock Funds
Category Insurance
Market Capitalization 0.00 USD
Volume 0.00 USD